ArticlePreventive medicine reports2026
Monitoring of tobacco product marketing for rapid public health surveillance in the United States.
Article in Preventive medicine reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Sentinel surveillance of vaping and emerging nicotine product use among university students: protocol for a longitudinal cohort study.BMC public health · 2026Article
- Accelerating tobacco regulatory science in the United States: The center for rapid surveillance of tobacco.Preventive medicine reports · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
The US tobacco landscape is constantly changing, with the commercial tobacco industry regularly flooding the market with new brands, flavors, and styles. Rutgers Center for Rapid Surveillance of Tobacco (CRST) examines tobacco product marketing, the tobacco product marketplace, and tobacco use behaviors. This paper describes how findings from tobacco marketing surveillance are integrated with other data sources to provide timely and actionable information about changes in tobacco products to inform the U.S. Food and Drug Administration's (FDA) regulatory efforts that reduce tobacco harms. CRST conducts regular surveillance of consumer-facing advertisements via print and online, business-to-business publications, direct-to-consumer marketing, branded tobacco company websites, and social media posts for over 50 brands. Information is disseminated through publication in peer-reviewed journals, public fact sheets, and weekly online newsletters to stakeholders. Geek Bar, an e-cigarette brand, illustrates how findings from CRST tobacco marketing surveillance are triangulated with data from other CRST activities to provide rapid information on an emerging brand. The presence of the brand was identified as a signal of interest in early sales data, whereafter surveillance of the brand's marketing activities showed frequent product releases and marketing targeting young people. This systematic tobacco marketing surveillance, when combined with other CRST activities, keeps regulators and the public health community informed in a constantly changing marketplace. CRST findings help to identify tobacco and nicotine products that pose the greatest threat to population health.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.